Acorda CEO Cohen on U.S. Budget Cuts, Research

March 22 (Bloomberg) -- Ron Cohen, chief executive officer of Acorda Therapeutics Inc., talks about the impact of U.S. budget cuts on medical research and drug development. Cohen, speaking with Sara Eisen and Tom Keene on Bloomberg Television's "Surveillance," also discusses China's investment in medical care and science. (Source: Bloomberg)

Why Can't Twitter Turnaround Monthly User Losses?
25:08 - Techonomy Media CEO David Kirkpatrick discusses his outlook for Twitter. Reddit co-founder lexis Ohanian and "Originals" Author Adam Grant also weigh in on "Bloomberg ‹GO›." (Source: Bloomberg)
  • The Fine Line Between Leadership Success and Failure
  • What Risks Do Emerging Markets Pose to U.S. Economy?
  • CFCT Head: EU Deal on Clearing Rules Good for Markets